Edith Cowan University

Research Online
Research outputs 2022 to 2026
11-1-2022

Anti-Müllerian hormone concentration is associated with central
adiposity and reproductive hormones in expectant fathers
Narelle C. Hadlow
Suzanne J. Brown
Ee Mun Lim
David Prentice
Simone Pettigrew

See next page for additional authors

Follow this and additional works at: https://ro.ecu.edu.au/ecuworks2022-2026
Part of the Endocrinology, Diabetes, and Metabolism Commons
10.1111/cen.14725
Hadlow, N. C., Brown, S. J., Lim, E. M., Prentice, D., Pettigrew, S., Cronin, S. L., ... & Yeap, B. B. (2022). Anti‐Müllerian
hormone concentration is associated with central adiposity and reproductive hormones in expectant fathers.
Clinical Endocrinology, 97(5), 634-642. https://doi.org/10.1111/cen.14725
This Journal Article is posted at Research Online.
https://ro.ecu.edu.au/ecuworks2022-2026/1369

Authors
Narelle C. Hadlow, Suzanne J. Brown, Ee Mun Lim, David Prentice, Simone Pettigrew, Sophie L. Cronin,
Susan L. Prescott, Desiree Silva, and Bu B. Yeap

This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworks2022-2026/1369

|

Revised: 10 March 2022

|

Accepted: 11 March 2022

DOI: 10.1111/cen.14725

ORIGINAL ARTICLE

Anti‐Müllerian hormone concentration is associated
with central adiposity and reproductive hormones
in expectant fathers
Narelle C. Hadlow1,2 | Suzanne J. Brown3 | Ee Mun Lim1,3,4 | David Prentice5
Simone Pettigrew6 | Sophie L. Cronin1 | Susan L. Prescott1,7,8 |
Desiree Silva1,7,9,10 |

|

Bu B. Yeap1,11

1

Medical School, University of Western Australia, Perth, Western Australia, Australia

2

Biochemistry Department, Sonic Healthcare, Clinipath Pathology, Perth, Western Australia, Australia

3

Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

4

Biochemistry Department, PathWest Laboratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

5

Perron Institute for Neurological and Translational Science, Perth, Western Australia, Australia

6

George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia

7

The ORIGINS Project, Telethon Kids Institute, Perth, Western Australia, Australia

8

Department of Immunology, Perth Children's Hospital, Perth, Western Australia, Australia

9

Department of Paediatrics, Joondalup Health Campus, Perth, Western Australia, Australia

10

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia

11

Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia, Australia

Correspondence
Bu Yeap, Medical School, University of
Western Australia, Perth, WA, Australia.
Email: bu.yeap@uwa.edu.au

Summary
Objective: The role of the anti‐Müllerian hormone (AMH) as an indicator of physical
and reproductive health in men is unclear. We assessed the relationships between
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AMH and follicle‐stimulating hormone (FSH), luteinizing hormone (LH), testosterone,
and metabolic parameters, in a cohort of expectant fathers.
Design: ORIGINS Project prospective cohort study.
Setting: Community‐dwelling men.
Participants: Partners of pregnant women attending antenatal appointments.
Main Outcome Measures: Serum AMH, FSH, LH, testosterone, and metabolic
parameters.
Results: In 485 expectant fathers, median age 33 years, median AMH was 40 pmol/L
(quartiles 29, 56). AMH was inversely correlated with FSH, age, and body mass index
(BMI) (correlation coefficients: −.32, −.24, and −.17 respectively). The age association
was nonlinear, with peak AMH between 20 and 30 years, a decline thereafter, and
somewhat steady levels after 45 years. The inverse association of AMH with FSH was
log‐linear and independent of age and BMI (β: −.07, SE: 0.01, p < .001). AMH was
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inversely correlated with waist circumference and directly associated with sex
hormone‐binding globulin. Testosterone was moderately correlated with AMH
(correlation coefficient: .09, β: .011, SE: 0.004, p = .014): this association was mediated
by an inverse relationship with BMI (mediated proportion 0.49, p < .001).
Conclusions: In reproductively active men, lower AMH is a biomarker for
advancing age, and for poorer metabolic and reproductive health. The inverse
association between AMH and FSH is independent of age and BMI, whereas the
association of AMH and testosterone is mediated via BMI. The utility of AMH to
predict reproductive and cardiometabolic outcomes in men warrants further
investigation.
KEYWORDS

AMH, BMI, FSH, men, ORIGINS Project, testosterone, waist circumference

1

| INTRODUCTION

2 |

The global increase in obesity across all age groups is expected to

2.1 |

M A T E R I A L S AN D M E T H O D S
Participants

lead to an increase in cardiovascular disease, stroke, and diabetes
and a probable decline in fertility. 1 In the 1990s, a review of

Partners of pregnant women involved in the ORIGINS Project at

61 publications including over 14,000 men found that semen

Joondalup Health Campus (JHC), Perth, WA, Australia were invited to

quality had declined over the prior 50 years. 2 The contribution of

participate. The ORIGINS Project is a community intervention birth

obesity to the decline in semen parameters continues to be

cohort‐based at the JHC, aiming to recruit mothers and follow up

explored.

3

their offspring for 5 years.17 Men whose partners are part of

Anti‐Müllerian hormone (AMH) is a glycoprotein of the

ORIGINS were invited to participate in a study of expectant fathers:

transforming growth factor‐β family produced by Sertoli cells. 4

the Cardiovascular Risk Evaluation in Expectant Fathers (CARE‐Dads)

AMH is helpful in paediatrics for sex differentiation and in adult

Study. Men requiring male factor fertility assistance were not

females for estimating female oocyte reserve.5 In adult males,

included in the study. Thus, the study cohort was drawn from

levels reflect Sertoli cell number and function.5,6 AMH receptors

healthy, fertile couples recruited after pregnancy had occurred. There

have been found in Leydig and Sertoli cells,5,6 testicular

were 503 expectant fathers participating in this study, from which 18

7

5

In mice,

were excluded, to provide a total of 485 reproductively active men in

AMH receptors have also been found in vascular smooth muscle

the analysis cohort. Exclusions included four females, 11 participants

cells and myocardium, suggesting a possible contribution to

with missing data, and three with outlying hormone data (two men

vascular disease.8,9

with luteinizing hormone [LH] < 1 IU/L, and one with a follicle‐

peritubular cells,

and hypothalamus and glial cells.

AMH in men is associated with specific cardiometabolic risk
10

stimulating hormone [FSH] elevated well above the reference interval

with higher AMH associated with lower all‐cause

of 24.8 IU/L). This study was approved by the Ramsay Health Care

mortality11 and with lower C‐reactive protein.12 Low AMH has

Human Research Ethics Committee (Approval Number 1536).

been associated with increased body mass index (BMI) and

All participants provided written informed consent.

factors

obesity,13–15 and there are complex relationships between AMH
and the hypothalamic–pituitary–gonadal (HPG) axis with AMH also
increasing gonadotrophin‐releasing hormone (GnRH) neuron activ-

2.2 |

Measurements

ity.5 Male reproductive capacity reflects gonadal and metabolic
health,16 and the role of AMH within these interrelationships

Participants completed a questionnaire assessing medical history and

remains unclear. Relationships between AMH, fertility hormones,

lifestyle behaviours. Participants were recorded as having hyper-

and metabolic factors including BMI and waist circumference in

tension, high cholesterol, or diabetes if they self‐reported a medical

reproductively active men are not well characterised. We studied a

diagnosis of the condition, or were on specific medications for the

unique cohort of expectant fathers for metabolic risk factors and

treatment of the condition. A physical assessment was conducted

reproductive hormone profiles, and investigated the relationship

measuring height, weight, and waist circumference (using a standard

of AMH to these parameters.

tape measure at the midpoint between the lowest lateral margin of
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the ribs and the highest lateral margin of the iliac crests, in the

ensure statistical validity of regression models. BMI measurements

horizontal plane). BMI was calculated as mass (kg) divided by height

were grouped into the categories <25, 25–29, 30–34, and ≥35 kg/m2

2

squared (m ). Heart rate and blood pressure (BP) were measured on

or treated as a continuous variable, as required. Similarly, age was

the right arm in the seated position with the elbow loosely flexed,

categorised as ≤30, 31–35, 36–40, or ≥41 years or treated as a

after 5 min of rest, using an automated digital BP monitor

continuous variable. In multiple regression analysis, predictors were

(Omron HEM7130; Omron Corporation).

checked for collinearity by evaluating variance inflation factors (VIF).
For the predictors BMI, testosterone, and SHBG, we evaluated the
possibility of mediatory effects on AMH using mediation analysis.

2.3

| Laboratory analysis

In this analysis, a predictor is partitioned into its direct effect on an
outcome and its effect due to mediation by a third variable, the

Blood samples were collected between 6:30 AM and 3:40 PM (lower

significance of each part is evaluated and the mediated proportion

quartile [LQ] 9:30 AM, median 10:45 AM and upper quartile [UQ]

calculated.

11:50 AM) into 5 ml serum separator tubes (BD Vacutainer®; Becton

A 5% significance level was used throughout. To allow for a

Dickinson), clotted at room temperature and then centrifuged within

maximum of four comparisons when assessing differences among

30 min at 1200 g for 10 min. Serum was decanted and frozen at

BMI or age categories, we adjusted the significance level to α' = .05/

−20°C until analysis. AMH was analysed according to manufacturer's

4 = .0125. All analysis was completed in the R statistical computing

guidelines using the electrochemiluminescence assay on Roche

environment (R version 4.0.0),21 including the mediation22 package.

Modular E170 initially and then on cobas e 601 from December
2019 (Roche Diagnostics GmbH). Coefficients of variation (CV) from
our internal quality controls at concentrations of 6.7, 32, and

3 |

RESULTS

97 pmol/L were 4.2%, 5.0%, and 4.9%, respectively. To convert
AMH values in pmol/L to ng/ml or µg/L divide results by 7.14. Serum
LH, FSH, sex hormone‐binding globulin (SHBG), and estradiol

3.1 | Baseline characteristics of the study
population

(E2) were analysed on the Roche Modular E170 and cobas e 601
(Roche Diagnostics, GmbH) according to the manufacturer's guide-

Descriptive statistics for the 485 reproductively active men were

lines. The same reagent kits were compatible with and used on both

stratified according to BMI and are shown in Table 1. The median age

the E170 and the e 601. Testosterone, dihydrotestosterone (DHT),

was 33 years, 32% of men had one or more previous children, and

androstenedione, 17‐hydroxyprogesterone (17‐OHP), and progester-

rates of hypertension, hypercholesterolemia, and diabetes were low.

one were analysed using liquid chromatography on Waters Xevo

Median AMH was 40 pmol/L (LQ: 29, UQ: 56), and this decreased

TQ‐S tandem quadrupole mass spectrometer (liquid chromatography

across categories of increasing BMI (Figure 1). Median values for

with tandem mass spectrometry) (Waters Corporation). The CVs for

testosterone and SHBG decreased across increasing categories of

testosterone were both 2.6% at testosterone concentrations of

BMI. Median LH was lowest in men with BMI 25–29 kg/m2.

5.3 and 28 nmol/L. LH values less than 8 U/L were defined as normal,
consistent with the laboratory reference interval. Testosterone
ranges vary with age. Baseline testosterone was within age‐specific
reference intervals in all men according to published data on men

3.2 | Inverse associations of AMH with FSH, age,
waist circumference, and BMI

aged 21–35 years (range 10.4–30.1 nmol/L)18 and additional
age‐specific reference intervals recently reported.19 The AMH

Correlations between AMH and other variables are shown in Table 2.

reference intervals for men in our laboratory are 20–120 pmol/L

AMH was inversely correlated with FSH, age, waist circumference,

for 19–40‐year‐olds and for >40 years 15–72 pmol/L. These intervals

and BMI (Spearman correlation coefficients [ρ]: −.32, −.24, −.20, and

were derived from local data, Roche method sheet data on male

−.17, respectively). These associations are illustrated in Figure 1 and

reference intervals, and literature.20

Figure S1.
There was a significant downward trend in log‐transformed AMH
with increased FSH concentration (β = −.069, p < .001, age adjusted;

2.4

| Statistical analysis

Figure 1). There was no evidence that the AMH‐FSH relationship
differed in men with BMI < 30 kg/m2 and those with BMI ≥ 30 kg/m2

Descriptive statistics are given as mean (SD) or, for skewed variables,

(pinteraction = .875).

median and LQ and UQ. Spearman correlation coefficients (ρ) were

Although age was correlated with both BMI and FSH, there was

calculated to evaluate relationships between AMH and reproductive

no evidence of collinearity when all were included in a multiple linear

hormones, BMI, waist circumference, and age. Linear regression

regression model (all VIF < 1.02), indicating that each is an indepen-

was used to refine the relationship between AMH and these

dent predictor of AMH. Of the variables examined, FSH accounted

variables, with adjustment for age and BMI. AMH and other hormone

for the largest proportion of variance in AMH with an R2 of 11.3%,

variables were log‐transformed where necessary before analysis to

compared with 4.9% for age and 3.2% for BMI.
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Demographic information for the whole CARE‐Dads cohort, then for BMI subgroups
All

BMI < 25

BMI 25–29

BMI 30–34

BMI ≥ 35

p

N

485

113

226

108

Age (years)

33 (30, 37)

32 (30, 35)

34 (30,37)

35 (31, 39)

155 (32%)

40 (35%)

74 (33%)

Smoker (yes)

59 (12%)

11 (10%)

Alcohol: Drinks/session

3.5 (2, 3.5)

Alcohol: Drinks/day

0.3 (0.1, 1)

High cholesterol

26 (5%)

3 (3%)

12 (5%)

8 (7%)

3 (8%)

.292

High BP

20 (4%)

1 (1%)

7 (3%)

8 (7%)

4 (11%)

.011

1 (0.4%)

1 (1%)

2 (5%)

.027

Existing children

Diabetes

4 (1%)
2

38
32 (29, 38)

.005

37 (34%)

4 (11%)

.008

31 (14%)

13 (12%)

4 (11%)

.79

3.5 (2, 3.5)

3.5 (2, 5.5)

3.5 (2.0, 3.5)

3.5 (2, 5.5)

.676

0.3 (0.1, 0.6)

0.4 (0.1, 1.3)

0.6 (0.1, 1.3)

0.3 (0.1, 0.6)

.077

0

BMI (kg/m )

28 (25, 31)

Waist (cm)

97 (89, 106)

85 (81, 89)

96 (92, 101)

108 (103, 111)

123 (117, 132)

<.001

Systolic BP (mmHg)

128 (120, 135)

124 (117, 131)

127 (119, 133)

132 (124, 139)

135 (129, 144)

<.001

Diastolic BP (mmHg)

80 (73, 86)

75 (68,81)

80 (74, 85)

86 (78, 93)

<.001

HbA1c (%)

5.1 (4.9, 5.3)

5.1 (4.9, 5.2)

5.1 (4.9, 5.3)

5.1 (4.9, 5.3)

5.2 (5, 5.6)

.023

AMH (pmol/L)

40 (29, 56)

45 (33, 62)

40 (30, 56)

37 (24, 50)

39 (23, 50)

.002

Testosterone (nmol/L)

16 (12, 20)

18 (15, 22)

16 (12, 20)

14 (12, 17)

11 (8.9, 14)

<.001

DHT (nmol/L)

1.0 (0.8, 1.4)

1.2 (1.0, 1.6)

1.1 (0.8, 1.4)

0.9 (0.7, 1.1)

0.7 (0.4, 0.9)

<.001

110 (88, 129)

108 (84, 125)

108 (87, 127)

113 (92, 132)

119 (103, 138)

.018

SHBG (nmol/L)

34 (25, 44)

42 (32, 52)

34 (25, 43)

31 (24, 38)

26 (17, 35)

<.001

LH (IU/L)

4.8 (3.6, 6.3)

5.0 (3.9, 6.9)

4.5 (3.6, 5.8)

5.0 (3.6, 6.4)

5.2 (3.8, 6.6)

.027

FSH (IU/L)

3.9 (2.9, 5.2)

4.0 (2.9, 5.4)

3.8 (3.0, 5.0)

3.9 (2.7, 5.0)

4.12 (2.9, 6.2)

.621

Androstenedione (nmol/L)

2.4 (1.9, 3.0)

2.5 (2, 3)

2.5 (1.9, 3.1)

2.4 (1.9, 2.9)

2.1 (1.7, 2.8)

.085

17‐Hydroxyprogesterone (nmol/L)

2.0 (1.4, 2.8)

2.4 (1.6, 3.4)

2 (1.4, 2.7)

2 (1.5, 2.6)

1.5 (1.1, 2.1)

<.001

0.13 (0.08, 0.20)

0.15 (0.08, 0.22)

0.13 (0.09, 0.20)

0.12 (0.08, 0.17)

0.09 (0.05, 0.15)

.006

E2 (pmol/L)

Progesterone (nmol/L)

83.5 (76, 89)

Note: Continuous variables: Median (LQ, UQ). Categorical variables: Count (%).
p‐value is from a Kruskal–Wallis test for continuous variables or Fisher's exact test for categorical variables.
Abbreviations: AMH, anti‐Müllerian hormone; BMI, body mass index; BP, blood pressure; CARE‐Dads, Cardiovascular Risk Evaluation in Expectant
Fathers; DHT, dihydrotestosterone; E2, estradiol; FSH, follicle‐stimulating hormone; HbA1c, hemoglobin A1c; LH, luteinizing hormone; LQ, lower quartile;
SHBG, sex hormone‐binding globulin; UQ, upper quartile.

3.3 | Associations of AMH with metabolic
parameters

Compared with males with a waist below 94 cm, those with a waist
measurement of 94–101 cm had AMH levels 12% lower (β = −.13,
p = .036), while males with a waist of 102 cm or more had AMH levels

Peak AMH occurred between 20 and 30 years of age and declined

17.5% lower on average (β = −.19, p < .001). Waist measurement and

thereafter (β = −.019, p < .001, for trend). There were significant

BMI were highly collinear predictors with respect to AMH

differences in AMH between the 20–30 year group and both the

(both VIF > 2.4), and AMH showed a slightly stronger association

36–40 and > 41‐year groups (both p < .001), but no significant

with waist than BMI (R2Waist = 4.1% vs. R2BMI = 3.2%).

difference between the youngest group and the 31–35‐year‐olds
(p = .070). After adjustment for age, AMH showed a significant
decrease over the BMI range (β = −.016, p = .002); however, there
was no evidence that the downward trend continued beyond the

3.4 | Associations of AMH with reproductive
hormones

30–34 kg/m2 category (p = .966 for comparison between 30 and
34 and ≥35 kg/m2 BMI categories; Figure 1).

As expected, serum testosterone was inversely correlated with age,

After adjustment for age, AMH showed a significant decrease

waist circumference, and BMI (ρ = −.12, −.38, and −.37, respectively;

over the waist measurement range (β = −.007, p < .001; Figure 1).

Table 3), and positively correlated with SHBG, DHT, and E2
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F I G U R E 1 Distribution of anti‐Mullerian hormone (AMH) concentrations in expectant fathers, stratified according to age, follicle‐stimulating
hormone (FSH), body mass index (BMI), and waist circumference categories. Data are shown as boxplots with AMH on the y‐axis, with median
and interquartile ranges for each category of age, FSH, BMI, and waist circumference. Quartile limits for FSH are: Q1: <2.9, Q2: 2.9–3.8, Q3:
3.9–5.1, Q4: >5.1 pmol/L

(ρ = .59, .75, and .36, respectively; Table 3). There was only a modest

BMI (ρ = −.34) and positively correlated with age (ρ = .16). When

positive association between serum testosterone and AMH (ρ = .09;

adjusted for age, the AMH–SHBG association was significant (β = .18,

Table 2). While in univariate analysis the AMH‐testosterone

p = .001); however, this result was slightly attenuated when further

association was significant (β = .011, p = .014), this result did not

adjustment was made for BMI (β = .14, p = .022). This attenuation

persist after adjustment for age and BMI (p = .376). We assessed

was attributed to a degree of collinearity between SHBG and BMI

whether this observation might reflect a case of mediation and found

(both VIF > 1.18).

no evidence that testosterone mediated the effect of BMI on AMH

The relationship between AMH and LH concentrations followed

(p = .248); conversely, there was strong statistical evidence that BMI

that of AMH and FSH, but with a much weaker degree of association

mediated 49% of the effect of testosterone on AMH (p < .001;

(ρ = −.09): there was a significant downward trend in age‐adjusted

estimate of the testosterone effect on AMH mediated by BMI was

AMH with increasing LH concentration (β = −.12, p = .039, LH

0.005, 95% confidence interval: 0.002–0.010).

log‐transformed), which persisted after further adjustment for BMI

Testosterone and SHBG were collinear and directly associated

(β = −.13, p = .030).

with AMH. There was a modest positive association between serum

There was a modest positive association between serum DHT and

SHBG and AMH (ρ = .08). Serum SHBG was inversely correlated with

AMH (ρ = .10; Table 2). In univariate analysis, the AMH‐DHT association
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T A B L E 2 Relationships between AMH
and other variables

639

Correlation

Linear regression adjustment

Relationship of
AMH with

ρ

Univariate β (p)

Age β (p)

Age and
BMI β (p)

R2

FSH

−.32

−.076 (<.001)

−.069 (<.001)

−.071 (<.001)

11.3%

Age

−.24

−.021 (<.001)

a

−.019 (<.001)

4.9%

Waist

−.20

−.008 (<.001)

−.007 (<.001)

b

4.1%

BMI

−.17

−.019 (<.001)

−.016 (.002)

c

3.2%

LH

−.09

−.16 (.010)

−.12 (.039)

−.13 (.030)

1.4%

SHBG

.08

.12 (.040)

.18 (.001)

.14 (.022)

0.9%

DHT

.10

.12 (.010)

.11 (.014)

NS

1.4%

Testosterone

.09

.011 (.014)

.008 (.054)

NS

1.2%

−.07

−.14 (.108)

−.19 (.025)

NS

0.5%

Estradiol
Androstenedione

.04

NS

NS

NS

0.7%

Progesterone

.09

NS

NS

NS

0.6%

17‐OHP

.05

NS

NS

NS

0.5%

Note: ρ is the Spearman correlation coefficient. Linear regression coefficient (β) and p‐value are from
linear regression of log‐transformed AMH against a given variable. LH, SHBG, and oestrogen were also
log‐transformed for regression analysis. R2 is from univariate regression analysis.
“NS” indicates the variable was not significant in the AMH regression model.
Abbreviations: 17‐OHP, 17‐hydroxyprogesterone; AMH, anti‐Müllerian hormone; BMI, body mass
index; DHT, dihydrotestosterone; FSH, follicle‐stimulating hormone; LH, luteinizing hormone; SHBG,
sex hormone‐binding globulin.
a

Linear model cannot be adjusted for age.

b
c

Linear model not adjusted for BMI, as waist and BMI are collinear.

Linear model cannot be adjusted for BMI

was significant (β = .12, p = .010); however, this result did not persist after

When time of blood sampling was tested as an explanatory

adjustment for age and BMI (p = .138). There was strong statistical

variable for each hormone, there was no association with AMH, FSH,

evidence that BMI mediated 44% of the effect of DHT on AMH

LH, DHT, or SHBG (all p > .05). Only testosterone (p < .001) and E2

(p = .008). Serum DHT was inversely correlated with BMI and positively

(p = .020) were associated with time. When time was tested as an

correlated with SHBG (ρ = −.38, .67, respectively; Table 3).

adjustment variable in the relationship between AMH and each of

There was no significant association between serum 17‐OHP

these hormones, there was no evidence of confounding from time of

and AMH, either before or after adjustment for age and BMI

blood sampling (AMH vs. testosterone p = .908; vs. FSH p = .512; vs.

(p = .118, .307, respectively). Serum 17‐OHP was inversely correlated

LH p = .759; vs. E2 p = .633; vs. DHT p = .947; vs. SHBG p = .779).

with BMI (ρ = −.20; Table 3).

Furthermore, there was no evidence of hormone–time interaction in
the relationships between AMH and each of these hormones
(all pinteraction > .05).

3.5

| Supplementary analyses

Of the 485 blood samples, 363 were analysed on the E170 and 122

4 |

D IS CU SS IO N

on the e 601. Median (LQ and UQ) AMH and FSH were comparable
between the two analysers (AMH 41.3 [29.7, 55.4] vs. 36.6 [24.4,

In a large group of expectant fathers, we found AMH was inversely

57.8] pmol/L, FSH 3.8 [2.8, 5.2] vs. 4.2 [3.1, 5.2] IU/L, both p > .05).

associated with FSH, age, waist circumference, and BMI. The

There were differences between analysers for SHBG, LH, and E2

inverse association of AMH with FSH was the strongest, was

(35.5 [26.4, 44.9] vs. 30.2 [23.1, 39.9] nmol/L; 4.6 [3.5, 6.2] vs. 5.2

independent of age and BMI, and was consistent across the range

[4.0, 6.7] IU/L; 108 [85, 125] vs. 119 [98, 139] pmol/L; all p < .05).

of FSH values. Testosterone and SHBG were both associated with

However, these differences did not significantly modify the

AMH, with evidence that for testosterone the association with

AMH–analyte relationships (AMH vs. SHBG, p = .273; AMH vs. LH,

AMH was mediated via the inverse association of testosterone

p = .239; AMH vs. E2, p = .299).

with BMI.
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TABLE 3

Correlation matrix for study variables
Age

BMI

Waist

T

DHT

17‐OHP

E2

BMI

0.13**

Waist

0.22**

0.89**

T

−0.12**

−0.37**

−0.38**

DHT

−0.04

−0.38**

−0.39**

0.75**

0.01

−0.20**

−0.19**

0.60**

0.37**

−0.11*

0.13**

0.12**

0.36**

0.16**

0.23**

0.59**

0.67**

0.26**

0.01
0.10*

17‐OHP
E2

ET AL.

SHBG

LH

SHBG

0.16**

−0.34**

−0.31**

LH

0.11*

0.00

0.04

0.07

0.00

0.14**

FSH

0.18**

−0.02

0.02

0.00

0.00

0.01

−0.08

0.09

0.46**

AMH

−0.24**

−0.20**

0.09*

0.10*

0.05

−0.07

0.08

−0.09*

−0.17**

FSH

0.05

−0.32**

2

Note: Age (years), BMI (kg/m ), waist circumference (cm), testosterone (T, nmol/L), dihydrotestosterone (DHT, nmol/L), estradiol (E2, pmol/L), sex
hormone‐binding globulin (SHBG, nmol/L), luteinising hormone (LH, IU/L), follicle‐stimulating hormone (FSH, IU/L), and anti‐Müllerian hormone (AMH,
pmol/L) in 485 expectant fathers. Spearman correlation coefficients (ρ) are shown.
Abbreviations: 17‐OHP, 17‐hydroxyprogesterone; BMI, body mass index.
*p < .05.
**p < .01.

There are strong genetic influences on AMH levels in men after
13

23

Our study

men with established gonadal dysfunction, there is an inverse

confirmed a cross‐sectional decline in AMH with increasing age,

association of AMH with FSH25 and FSH increases with age.32,33

which is consistent with previous studies. Both testosterone

However, it is unclear if other metabolic factors including BMI

production and spermatogenesis demonstrate impairment during

influence the relationship between AMH and FSH. In a study of men

puberty

and a high degree of interpersonal variation.

on the relationship of AMH and FSH in reproductively active men. In

the course of male ageing.

24,25

Our results are consistent with

with maldescended testes, FSH had a negative correlation with AMH

previous observations that reduced AMH in older men may reflect

but was not associated with AMH in healthy men.34 In a larger study

20,25,26

age‐related reductions in Sertoli cell function.

Of note a study

of healthy men, a negative association between AMH and FSH was

of 970 young men (median age 19 years) found no association

thought to indicate an age‐related reduction in testicular function.26

between serum AMH and semen quality, except for a trend for a

However, in our data, the inverse relationship between FSH and

lower percentage of normal morphology with higher AMH.27

AMH persisted even when controlling for age and obesity.

We found an inverse relationship between AMH and BMI and

An elevated FSH can reflect Sertoli cell dysfunction, with

AMH and waist circumference. There was a direct relationship

compensatory feedback driving pituitary FSH secretion.6 A recent study

between AMH and SHBG. The relationships between BMI, waist

by Waller et al.35 found that an FSH above age and method‐specific

circumference, and AMH are of interest given impaired reproductive

reference intervals conveyed an increased risk of semen abnormality

health with increasing obesity.14,28,29 BMI increases with age,

and infertility. FSH regulates Sertoli cell function and subsequent

particularly in middle‐aged adults.30,31 BMI is inversely associated

production of AMH and inhibin B.6 Our findings indicate AMH may

with testosterone, SHBG, and inhibin B

14,15,28

and semen quality can

provide additional independent information regarding Sertoli cell

be impaired with increasing BMI.14,28,29 Our findings of lower AMH

function in reproductively active men, even when other factors

with increasing BMI are consistent with other studies. There is

associated with metabolic and cardiovascular health are considered.

evidence for an inverse association between AMH and BMI, and

GnRH neuronal activity and GnRH release.5 FSH has a role in

inversely associated with waist circumference in obese men and

promoting fat accumulation and there are FSH receptors in adipocytes

there was an inverse relationship between AMH and diabetic status.

where FSH promotes lipid biosynthesis.36 FSH can also induce

A nonsignificant trend for decreasing AMH with BMI was also

dose‐dependent increases in leptin and decreases in adiponectin

Our results are concordant with these findings suggest-

production in cultured human adipocytes.36 Therefore, our findings of

ing that lower AMH may be a marker of obesity and metabolic

inverse associations of AMH with BMI, waist circumference, and FSH

dysfunction.

reflect these complex interactions between metabolic and reproduc-

observed.

10

A recent NHANES study

10

Of note, AMH has actions in the HPG axis to increase

found AMH was

AMH and fat mass.

13–15

In expectant fathers, we found the strongest inverse association

tive health.

to be between AMH and FSH. This relationship remained robust after

Obesity is associated with a longitudinal decline in circulating

controlling for other factors that reduce AMH, such as increasing age,

testosterone concentrations.37 We found a direct association between

BMI, and waist circumference. Surprisingly there is little information

AMH and testosterone. This was mediated to a large extent by BMI, in
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contrast to the independent and inverse association of AMH with FSH.

members of ORIGINS Community Reference and Participant Reference

Therefore, although AMH is inversely associated 3with both age and

Groups; Research Interest Groups; and the ORIGINS Scientific

BMI, via its associations with FSH and testosterone, it provides further

Committee. This study is a subproject of the ORIGINS Project. Open

insights into reproductive health in expectant fathers. Androstenedi-

access publishing facilitated by The University of Western Australia, as

one, progesterone, and 17‐OHP were not correlated with AMH in

part of the Wiley ‐ The University of Western Australia agreement via

univariate, age, or age and BMI‐adjusted analyses, suggesting less of a

the Council of Australian University Librarians.

role for the ACTH/adrenal gland axis.
Strengths of the study include the large cohort of expectant fathers,
providing a novel opportunity to examine the interactions of AMH with
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